Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03240328
PHASE1
The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function
Sponsor: Guangzhou 8th People's Hospital
View on ClinicalTrials.gov
Summary
To study the safety and effectiveness of CAR-T Cell therapy on HIV patients whose plasma HIV has been successfully suppressed after cART, which is expected to enhance the res-constitution of HIV-specific immune function to assist the eradication of HIV reservoir.
Official title: The Effect of CAR-T Cell Therapy on the Reconstitution of HIV-specific Immune Function
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2017-10-04
Completion Date
2030-12-31
Last Updated
2022-09-14
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
CAR-T cells
HIV-1 specific chimeric antigen receptor cells
Locations (1)
Guangzhou 8th People's Hospital
Guangzhou, Guangdong, China